EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer Therapy

Wonbeom Park, Jiwoong Choi, Jaehyeon Hwang, Suhyun Kim, Yelee Kim iD, Man Kyu Shim iD, Wooram Park, Seokhyeon Yu, Sangwon Jung, Yoosoo Yang iD, Dae-Hyuk Kweon iD

ACS Nano · 18.02.2025 · 19 (6) · 6412-6425

DOI: 10.1021/acsnano.4c16562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 05.02.2025. Verfasst von Wonbeom Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Trastuzumab, Lipids. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, MessengerTrastuzumabLipidsApolipoproteinsNeoplasmsHumansAnimalsMiceCell Line, TumorFemaleLiposomes

Stichwörter der Autor:innen

antibodyapolipoproteincancergene therapylipid nanoparticle (LNP)mRNAtargeted delivery

Substanzen

RNA, MessengerTrastuzumabLipidsApolipoproteinsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Department of Life Sciences, Korea University, Seoul 02841, Republic of Korea.
  • Research Center, MVRIX, Anyang 14058, Republic of Korea.
  • Division of Bio-Medical Science and Technology, KIST School, Korea University of Science and Technology, Seoul 02792, Republic of Korea.

ORCID-Profile: Yelee Kim, Man Kyu Shim, Yoosoo Yang, Dae-Hyuk Kweon

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Park, W., Choi, J., Hwang, J., Kim, S., Kim, Y., Shim, M. K., Park, W., Yu, S., Jung, S., Yang, Y., & Kweon, D. H. (2025). Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer Therapy. ACS Nano, 19(6), 6412-6425. https://doi.org/10.1021/acsnano.4c16562

Vancouver

Park W, Choi J, Hwang J, Kim S, Kim Y, Shim MK, et al. Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer Therapy. ACS Nano. 2025;19(6):6412-6425. doi:10.1021/acsnano.4c16562

BibTeX
@article{Park2025,
  author = {Park, Wonbeom and Choi, Jiwoong and Hwang, Jaehyeon and Kim, Suhyun and Kim, Yelee and Shim, Man Kyu and Park, Wooram and Yu, Seokhyeon and Jung, Sangwon and Yang, Yoosoo and Kweon, Dae-Hyuk},
  title = {Apolipoprotein Fusion Enables Spontaneous Functionalization of mRNA Lipid Nanoparticles with Antibody for Targeted Cancer Therapy},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {6},
  pages = {6412--6425},
  doi = {10.1021/acsnano.4c16562}
}
Kostenlos starten →